🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alexander Egeberg

University of Copenhagen

ORCID: 0000-0001-8257-1816

Also affiliated with Frederiksberg Hospital, Bispebjerg Hospital

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
0.945Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5‐year data from reSURFACE 1 and reSURFACE 2

Journal of the European Academy of Dermatology and Venereology(2022)10.1111/jdv.18167
Top 21%
0.945DataRank
Top 21%23 citations

E. Daudén, Sascha Gerdes, Mark Lebwohl, Alan Menter, C. Leonardi +11 more

Papers

Driven by 4 papers — median percentile 79. Top paper: “Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea”.

Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea

JAMA Dermatology(2022)10.1001/jamadermatol.2022.0526
N/A
1.5DataRank · unranked
56 citations

Amalie Thorsti Møller Rønnstad, Maria O. Christensen, Claus Zachariae, Nita K. F. Wienholtz, Anne-Sofie Halling +5 more

Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5‐year data from reSURFACE 1 and reSURFACE 2

Journal of the European Academy of Dermatology and Venereology(2022)10.1111/jdv.18167
Top 21%
0.945DataRank
Top 21%23 citations

E. Daudén, Sascha Gerdes, Mark Lebwohl, Alan Menter, C. Leonardi +11 more

Predicting discontinuation of biologic therapy caused by adverse events in psoriasis patients—A Danish nationwide cohort study

JEADV Clinical Practice(2023)10.1002/jvc2.219
N/A
0DataRank · unranked
0 citations

Troels C. Petersen, Julia‐Tatjana Maul, Jashin J. Wu, Trine Bertelsen, Lone Skov +4 more

Bariatric Surgery and Risk of New-onset Inflammatory Bowel Disease: A Nationwide Cohort Study

Journal of Crohn s and Colitis(2021)10.1093/ecco-jcc/jjab037
N/A
0DataRank · unranked
24 citations

Rikke Kart Jacobsen, Ryan C. Ungaro, Jean‐Frédéric Colombel, Alexander Egeberg, Marie Villumsen +2 more